Skip to content

Enbrel 50 mg solution for injection in pre-filled pen

DRUG4 trials

Sponsors

Queen Mary University Of London, UZ Leuven, IRCCS Istituto Giannina Gaslini, Sint Maartenskliniek Stichting

Conditions

Juvenile idiopathic arthritisRheumatoid ArthritisRheumatoid arthritis

Phase 4

The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
RecruitingCTIS2022-502021-18-00
Queen Mary University Of LondonRheumatoid Arthritis
Start: 2023-10-12Target: 182Updated: 2026-01-19
RCT part: CareRA2020: Effectiveness of a combination of Methotrexate and a step down glucocorticoid regimen (COBRA-Slim) for remission induction in patients with early Rheumatoid Arthritis (RA), with or without fast access to 24 weeks of Tumor Necrosis Factor (TNF) blockade in insufficient responders, a randomized, multicenter, pragmatic trial. LTE part: CareRA2020 LTE: a 3 year longitudinal observational, multicenter, follow-up of early RA patients after participation in the CareRA2020 RCT.
CompletedCTIS2023-510189-28-00
UZ LeuvenRheumatoid Arthritis
Start: 2018-05-15End: 2025-07-08Target: 442Updated: 2024-02-01
Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized clinical trial comparing early versus late drug withdrawal combining imaging and multi-Omics.
RecruitingCTIS2024-514732-24-00
IRCCS Istituto Giannina GasliniJuvenile idiopathic arthritis
Start: 2025-04-28Target: 328Updated: 2025-08-26
DISCO-RA:DIScontinuation of COncomitant disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis patients also using TNF inhibitors - a randomized long-term non-inferiority strategy trial
Not yet recruitingCTIS2026-525316-33-00
Sint Maartenskliniek StichtingRheumatoid arthritis
Target: 202Updated: 2026-06-09